Evidence map›Paper›PMID 21061160›Full record

ArticleCellular and molecular neurobiology2010

Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease.

Yuqing Chen, Fangwen Rao, Gen Wen, Jiaur R Gayen, Kuixing Zhang, Sucheta M Vaingankar, Nilima Biswas, Manjula Mahata, Ryan S Friese, Maple M Fung and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. The role of chromogranin A cleavage products in onset of type 1 and 2 diabetes.Frontiers in clinical diabetes and healthcare · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.Laboratory investigation; a journal of technical methods and pathology · 2016
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Yuqing ChenRenal Division, Peking University First Hospital, Beijing 100034, China.
Fangwen Rao
Gen Wen
Jiaur R Gayen
Kuixing Zhang
Sucheta M Vaingankar
Nilima Biswas
Manjula Mahata
Ryan S Friese
Maple M Fung
Rany M Salem
Caroline Nievergelt
Vibha Bhatnagar
Vivian Y Hook
Michael G Ziegler
Sushil K Mahata
Bruce A Hamilton
Daniel T O'Connor
University of California, San Diego · USVA San Diego Healthcare System · USPeking University · CN

Funding

Trafficking of catecholamine storage vesicle proteinsP01HL058120 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI O'CONNOR, DANIEL T · 1999 to 2009
$18.5M
Homeostatic regulation of autonomic physiology by chromogranin AR01HL108629 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VAINGANKAR, SUCHETA M · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL108629
6 · The paper itself

Abstract

Chromogranin A (CHGA) plays a fundamental role in the biogenesis of catecholamine secretory granules. Changes in storage and release of CHGA in clinical and experimental hypertension prompted us to study whether genetic variation at the CHGA locus might contribute to alterations in autonomic function, and hence hypertension and its target organ consequences such as hypertensive renal disease (nephrosclerosis). Systematic polymorphism discovery across the human CHGA locus revealed both common and unusual variants in both the open reading frame and such regulatory regions as the proximal promoter and 30-UTR. In chromaffin cell-transfected CHGA 30-UTR and promoter/luciferase reporter plasmids, the functional consequences of the regulatory/non-coding allelic variants were documented. Variants in both the proximal promoter and the 30-UTR displayed statistical associations with hypertension. Genetic variation in the proximal CHGA promoter predicted glomerular filtration rate in healthy twins. However, for hypertensive renal damage, both end-stage renal disease and rate of progression of earlier disease were best predicted by variants in the 30-UTR. Finally, mechanistic studies were undertaken initiated by the clue that CHGA promoter variation predicted circulating endothelin-1. In cultured endothelial cells, CHGA triggered co-release of not only the vasoconstrictor and pro-fibrotic endothelin-1, but also the pro-coagulant von Willebrand Factor and the pro-angiogenic angiopoietin-2. These findings, coupled with stimulation of endothelin-1 release from glomerular capillary endothelial cells by CHGA, suggest a plausible mechanism whereby genetic variation at the CHGA locus eventuates in alterations in human renal function. These results document the consequences of genetic variation at the CHGA locus for cardiorenal disease and suggest mechanisms whereby such variation achieves functional effects.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationChromogranin AHumansHypertension, RenalKidneyKidney Function TestsNephrosclerosisPhenotypeSex CharacteristicsCHGA protein, humanChromogranin A

Identifiers

PMID21061160
PMCPMC3008929
OpenAlexW2092589835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.